Previous Article | Next Article ![]()
Infection and Immunity, August 1999, p. 3989-3997, Vol. 67, No. 8
Departments of Obstetrics & Gynecology1 and
Pathology,2 The University of Texas
Medical Branch, Galveston, Texas
Received 18 February 1999/Returned for modification 30 March
1999/Accepted 20 May 1999
Escherichia coli strains expressing Dr fimbriae are
able to enter epithelial cells by interacting with a
complement-regulatory protein, decay-accelerating factor. This model of
bacterial internalization, with a well-characterized bacterial ligand
and host receptor, provides a unique opportunity to investigate the
early stages of invasion. We used immunofluorescence staining
techniques to examine the distribution of receptor and cytoskeletal
proteins in HeLa cells infected with E. coli recombinant
strains that expressed Dr family of adhesins: Dr, Dr-II, F1845, AFA-I,
and AFA-III. A major rearrangement of decay-accelerating factor was
found at the adherence sites of recombinant strains expressing Dr,
Dr-II, and F1845 adhesins. The changes in the distribution of receptor were significantly smaller on HeLa cells infected with E. coli bearing AFA-I or AFA-III afimbrial adhesins. Receptor
aggregation was associated with the redistribution of
cytoskeleton-associated proteins such as actin, Escherichia coli bearing
Dr fimbriae or the related adhesins afimbrial adhesin I (AFA-I),
afimbrial adhesin III (AFA-III), or F1845 adhesin is associated with
urinary tract infections and diarrhea (5, 18). Despite
similar genetic organization, the phenotypic expression among the Dr
family of adhesins is associated with either fimbrial or afimbrial
morphology. These morphological differences are attributed to the amino
acid sequence of the major structural subunit. All members of the
family display a similar pattern of binding to the natural receptor,
decay-accelerating factor (DAF; CD55) (17). DAF, a
complement regulatory protein expressed on most mammalian cells,
consists of four 60-amino-acid short consensus repeat (SCR) domains and
a serine/threonine-rich region followed by a carboxyl-terminal domain
that allows the association with glycophosphatidylinositol anchor (GPI)
(14). DAF protects cells from autologous complement-mediated
damage by preventing the formation of C3 convertases. Recently, DAF has been recognized as a cell attachment receptor for coxsackievirus A21
and a number of hemagglutinating enteroviruses (1, 11, 21).
One characteristic feature of GPI-anchored proteins is their lateral
membrane mobility, which facilitates coupling to signaling molecules
(20). Binding of the antibody to GPI-anchored protein can
lead to cell activation. This effect is enhanced by anti-immunoglobulin
antibodies, which promote clustering of cell surface immune complexes.
Studies in which DAF is used as a model GPI-anchored protein
demonstrated that DAF redistributes to a pole of T lymphocytes after
incubation with anti-DAF monoclonal antibodies and anti-mouse
immunoglobulin G (10). The redistribution (capping) of DAF
was associated with cytoskeleton reorganization. GPI-anchored molecules
associate with protein tyrosine kinases, which are important regulators
of signal transduction (23). A DAF complex with the two src
family protein tyrosine kinases p56lck and
p59fyn was found in the murine thymoma EL-4 cell
line transfected with DAF (22). The association between DAF
and protein tyrosine kinases has also been found in the HeLa epithelial
cell line (22). These studies pointed out a possible
signaling pathway after DAF was cross-linked.
We have recently shown that the expression of E. coli Dr
fimbrial operon allows bacteria to invade the epithelial cells
(7). The Dr-positive clinical strain E. coli
IH11128 and recombinant strain BN406 were able to enter cultured HeLa
cells; the DraE-negative mutant was not. Binding of Dr-positive
E. coli is a result of the interaction between bacterial
adhesin and the short consensus repeat 3 (SCR3) domain of DAF. The
monoclonal anti-SCR3 antibody is a potent inhibitor of receptor binding
and subsequent invasion mediated by Dr fimbriae (17).
Immunoelectron microscopy studies revealed morphologic interactions
between DAF expressed on HeLa cells and bacterial ligand at the initial
stages of internalization (7). The cellular cytoskeleton was
involved in the process of internalization, since bacterial entry was
prevented entirely by the microtubule inhibitor nocodazole and less
efficiently by microfilament inhibitor cytochalasin D. In contrast to
classic invasive pathogens like Salmonella or
Shigella, with unknown receptor specificity, the advantage
of our model of bacterial internalization relies on the fact that both
components of the entry process, host receptor and bacterial ligand,
are well characterized. This provides a unique opportunity to
investigate how early bacterium-host cell interaction affects the
distribution of receptor, cytoskeleton proteins, and intracellular signaling.
We hypothesized that binding of bacterial ligand might cause
cross-linking of DAF. Following the clustering of DAF, cytoskeleton proteins rearrange to provide motor forces for bacterial entry. In this
study, we used immunofluorescence (IF) techniques to compare the
receptor and cytoskeletal component distribution in the HeLa epithelial
cell line after interaction with Dr fimbriae and other members of Dr
adhesin family. Electron microscopy was used to provide evidence that
interaction of epithelial cells with purified Dr fimbriae promotes
bacterial internalization.
Recombinant strains.
The comparative studies of the
interaction of E. coli recombinant strains bearing adhesins
of the Dr family with epithelial cells may hypothetically be affected
by the expression of adhesin operons in different vectors and in
various host strains. The HindIII-HindIII
11.4-kb DNA fragment containing the Dr operon was originally expressed
in the pACYC184 vector and carried in laboratory strain EC901
(16). The BamHI-HindIII 7.5-kb DNA
fragment encoding the F1845 adhesin was expressed in the pUC18 vector
and carried in E. coli LE392 (2). The 8.7-kb
XhoI-HindIII fragment coding for Dr-II
adhesin was expressed in pBluescript SK-II in E. coli DH5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Decay-Accelerating Factor and Cytoskeleton
Redistribution Pattern in HeLa Cells Infected with Recombinant
Escherichia coli Strains Expressing Dr Family of
Adhesins
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-actinin, ezrin, and
occasionally tropomyosin. Purified Dr fimbriae coated on polystyrene
beads were capable of triggering clustering of receptor and
accumulating actin at the adhesion sites of beads to HeLa cells. Using
scanning and transmission electron microscopic techniques, we have
shown that beads coated with Dr fimbriae, as opposed to beads coated
with bovine serum albumin, were enwrapped by cellular microvilli and ultimately internalized into HeLa cells. This indicates that
interaction of Dr fimbriae with decay-accelerating factor is associated
with redistribution of receptor and is sufficient to promote bacterial internalization.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
(19). The EcoRI 6.7- and 8-kb fragments encoding AFA-I and AFA-III adhesins were originally expressed in pBR322 in two
different E. coli host strains, HB101 and MC1061,
respectively (12, 13). The DNA fragments containing operons
of the Dr family of adhesins were mobilized from original vectors,
ligated in the medium- to low-copy-number vector pBR322, and
transformed to laboratory host strain E. coli DH5
. All
procedures were performed by standard molecular biology methods
(15).
transformed with
vector pBR322 and new constructs expressing Dr, Dr-II, F1845, AFA-I, and AFA-III adhesins on Luria (L) agar plates containing ampicillin (100 µg/ml). We also included the invasive strain Shigella
flexneri SA100, which does not exploit DAF, as a receptor to
evaluate DAF distribution in infected HeLa cells. We used a suspension
of each strain made in phosphate-buffered saline (PBS) from overnight cultures and adjusted to an optical density at 600 nm
(OD600) of 1.9 at to infect HeLa cell monolayers.
MAC assay.
The minimal agglutinating concentration (MAC)
assay was performed with and without inhibitor substances,
methyl-
-D-mannoside (1.1 mM) and chloramphenicol (5 mM)
(Sigma Chemical Co., St. Louis, Mo.), to assess the amount of adhesin
expressed by recombinant strains. The solution of inhibitors was
prepared in PBS. The bacterial suspensions in PBS (OD600,
1.9) were prepared from overnight cultures grown on L agar with
ampicillin (100 µg/ml). Twofold dilutions were made in PBS in the
range from 1:2 to 1:4,096. To determine MAC, 20 µl of bacterial
suspension was mixed on an agglutination plate with 30 µl of 3%
suspension of human erythrocytes in PBS. The mixture was incubated for
5 min in a wet chamber with gentle rotation. The plate was examined for
the highest dilutions showing hemagglutination.
Cell line. The HeLa human cervical cell line (ATCC CCL2) was maintained in minimum essential medium Cellgro Eagle (Mediatech, Inc., Herndon, Va.) containing Earle's salts and L-glutamine and supplemented with 10% heat-inactivated fetal calf serum.
Antibodies.
Bodipy FL Phallacidin was purchased from
Molecular Probes, Inc. (Eugene, Oreg.), and used as recommended by the
supplier. The mouse monoclonal anti-
-tubulin (clone DM 1A),
anti-
-tubulin (clone TUB 2.1), anti-
-actinin (clone BM75.2),
antitalin (clone 8d4), antivinculin (clone hVIN-1), and antitropomyosin
(clone TM 311) antibodies were purchased from Sigma Chemical Co., and monoclonal antiezrin antibody (clone 18) was obtained from Transduction Laboratories (Lexington, Ky.). The monoclonal antibodies to the SCR-1
domain of DAF (clone 2D2-8) were kindly provided by John Moulds (Gamma
Biologicals Inc., Houston, Tex.). Secondary goat anti-mouse antibodies
and goat anti-rabbit antibodies conjugated with Oregon Green or Texas
Red were purchased from Molecular Probes, Inc., and used at a dilution
of 1:100 (20 µg/ml).
Purification of Dr fimbriae. The recombinant strain bearing Dr fimbriae was grown overnight on L-agar plates with ampicillin (100 µg/ml). The bacteria were suspended in PBS. The suspension was vortexed for 5 min and centrifuged for 10 min at 10,000 × g in SS-34 centrifuge tubes. The supernatants were filtered through a 0.22-µm-pore-size membrane. Fimbrial protein was purified from the filtrate by ammonium sulfate precipitation and size exclusion chromatography. The column was connected to the Econo low-pressure liquid chromatography system (Bio-Rad, Hercules, Calif.). The eluted fimbriae were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (15% acrylamide).
Coating of polystyrene beads with purified Dr fimbriae. Plain beads (Polybead polystyrene beads composed of 2.5% solid polystyrene; diameter, 1.072 µm; Polyscience, Inc., Warrington, Pa.) were diluted 1:10, washed three times with centrifugation, and resuspended in 0.1 M borate buffer (pH 8.5). A thawed fimbrial preparation containing 75 µg of purified fimbrial protein per ml was diluted 1:10 in the suspension of polystyrene beads. The control beads were mixed with a solution of albumin (bovine serum albumin [BSA], fraction V; Sigma Chemical Co.) to the same final concentration of protein as in the fimbrial sample. The suspensions were mixed end to end overnight at room temperature. Next, the suspensions were centrifuged for 5 min, resuspended in PBS containing 1% BSA and 0.1% glycerol (storage buffer), and kept at 4°C until assayed. The biological activity of beads coated with purified Dr fimbrial protein was confirmed by mannose-resistant, chloramphenicol-inhibitable agglutination of human erythrocytes. The Dr fimbria-coated beads also agglutinated with rabbit polyclonal anti-Dr serum.
Incubation of bacterial or polystyrene bead suspensions with HeLa cells monolayer. Bacterial suspensions in PBS (OD600, 1.9) were diluted 1:100 in prewarmed minimal essential medium, added to HeLa cells monolayers grown on coverslips (15 mm in diameter) in 12-well tissue culture plates, and incubated for 3 h at 37°C under 5% CO2. The coverslips were washed three times with PBS, fixed for 10 min with 3% paraformaldehyde in PBS, washed with PBS, and permeabilized for 2 min with 0.1% Triton X-100. Permeabilization was omitted with monolayers subsequently stained for DAF. Similarly, the polystyrene beads coated with purified Dr fimbrial protein or BSA-coated control beads were diluted 1:10 in culture medium and incubated with the monolayer for the desired time. After being washed, the monolayers were processed in the same way as those incubated with bacterial suspensions.
IF staining.
The staining for polymerized actin was
performed with Bodipy FL Phallacidin as recommended by the
manufacturer. To visualize
-actinin, ezrin, talin, tropomyosin,
tubulin, and vinculin, the paraformaldehyde-fixed monolayers were
incubated for 20 min with 10% normal goat serum in PBS (blocking
solution). They were subsequently incubated for 30 min with appropriate
primary monoclonal antibodies diluted 1:50 in a solution of 1% BSA and
2% normal goat serum in PBS. In control staining, the primary antibody
was replaced with preimmune mouse serum. After two washings with PBS,
the cells were incubated for 30 min with goat anti-mouse secondary
antibodies conjugated with Texas Red. Finally, the coverslips were
stained with SYTO 9 (Molecular Probes, Inc.) to visualize cellular
structures and individual bacterial cells. In some experiments, the
double IF staining was performed to colocalize Dr fimbrial antigen.
Slides were examined under an Eclipse 600 microscope (Nikon Inc.,
Melville, N.Y.) equipped with an epifluorescence attachment, Texas Red
filter, double-pass Texas Red-fluorescein isothiocyanate filter, and
U-III camera system.
Electron microscopy. (i) SEM. Monolayers on coverslips for scanning electron microscopy (SEM) were fixed with a mixture of 1.25% formaldehyde, 2.5% glutaraldehyde, 0.03% trinitrophenol, and 0.03% CaCl2 in 0.05 M cacodylate buffer (pH 7.3) for at least 1 h at room temperature, postfixed in 1% OsO4 in 0.1 M cacodylate buffer, dehydrated in ethanol, treated with hexamethyldisalazane, and air dried (8). Next, the coverslips were mounted onto the stubs and sputter coated with palladium-gold alloy in a Bal-Tec SCD-004 Sputter Coater (Technotrade International, Manchester, N.H.) at 15 mA for 2 min. Samples were examined in a 525M scanning electron microscope (Philips Electron Optics, Eindhoven, The Netherlands) at 15 kV and at magnifications from ×3,000 to ×20,000.
(ii) TEM. Monolayers for transmission electron microscopy (TEM) were fixed as for SEM, but between the fixation steps they were washed and scraped off the coverslips or plastic support and further processed as a pellet. They were stained en bloc with 1% uranyl acetate in 0.1 M maleate buffer (pH 5.2), dehydrated in ethanol, and embedded into Poly/Bed 812 resin (Polysciences, Inc). Ultrathin sections were cut on a Sorvall MT-6000 ultramicrotome (RMC, Tucson, Ariz.), stained with aqueous uranyl acetate and lead citrate, and examined in a Philips 201 transmission electron microscope at 60 kV.
| |
RESULTS |
|---|
|
|
|---|
The binding of recombinant E. coli expressing Dr
adhesins triggers different patterns of distribution of DAF at the site
of bacterial attachment.
The interaction of an invasive bacterial
pathogen like Salmonella typhimurium with mammalian cells
may lead to significant clustering of the host cell surface proteins
(6). We have used an IF double-staining technique to
evaluate the changes in the DAF staining pattern at different time
points after infection with E. coli recombinant strains
bearing Dr fimbriae and other related adhesins. The double staining
allowed colocalizing of the targeted cellular proteins and bacterial
cells interacting with the monolayer. Significant differences were
observed between the members of the Dr family. The noninfected
monolayers of HeLa cells displayed an even distribution of granule-like
staining with monoclonal antibodies raised to different domains of DAF (results not shown). The infection of HeLa cells with recombinant strains expressing Dr, Dr-II, and F1845 adhesins was associated with a
rapid (15-min infection) and extensive redistribution of the receptor.
The receptor formed tight profiles outlining the sites of bacterial
interaction with the monolayer (Fig. 1A).
HeLa cells infected with recombinant E. coli strains bearing
AFA-I or AFA-III adhesins displayed shadow-like staining patterns
corresponding to bacteria outlined by minute amounts of accumulated DAF
(Fig. 1B, Table 1). The differences
between the constructs in the agglutination titer of human erythrocytes
did not affect the patterns of redistribution of DAF. For example,
E. coli bearing F1845 fimbriae with the highest MAC
(1:2,048) and E. coli expressing Dr hemagglutinin with a low MAC (1:64) do not differ in the pattern and intensity of DAF
clustering. The DAF staining pattern on a monolayer infected with
control invasive strain S. flexneri SA 100 (Fig. 1C) or with
E. coli laboratory strain DH5
carrying the pBR322 vector
remained unchanged and did not differ from that found in noninfected
cells.
|
|
E. coli bearing adhesins of Dr family trigger different
patterns of accumulation of cytoskeleton proteins in infected HeLa
cells.
We have tested whether the infection of epithelial cells
with recombinant E. coli strains carrying the Dr family of
adhesins is associated with the redistribution of actin and
actin-associated molecules. Infection of HeLa cells with recombinants
carrying Dr, Dr-II, F1845, and AFA-I resulted in an accumulation of
polymerized actin that completely or partially outlined individual
adherent bacterial cells (Fig. 2A, Table
1). The first signs of actin redistribution were visible 10 to 15 min
after actin was added to the bacteria. There was no evidence of actin
redistribution in HeLa cells infected with E. coli
expressing AFA-III adhesin (Table 1). A similar staining pattern was
found with antibodies to
-actinin (Fig. 2B) and ezrin (Fig. 2C).
Both molecules accumulated at the sites of bacterial binding and formed
tight profiles outlining individual bacterial cells. Tropomyosin
accumulated at the sites of bacterial attachment on cells infected with
E. coli bearing Dr fimbriae and occasionally on HeLa cells
incubated with Dr-II, AFA-I, and F1845 adhesins (Fig. 2D, Table 1).
Cytoskeleton-associated proteins did not accumulate in monolayers
infected with E. coli carrying the pBR322 vector. In
addition, the redistribution was not seen on slides where primary
antibodies were replaced with preimmune mouse serum (results not
shown). Focal contact proteins, such as talin and vinculin, were not
affected by adherence of recombinant E. coli strains bearing
Dr family of adhesins (Table 1).
|
The microtubules are involved in the internalization of Dr-positive
E. coli but do not undergo redistribution.
We have
found that internalization of Dr-positive E. coli is almost
completely prevented by the microtubule inhibitor nocodazole (7). To estimate whether interaction of E. coli
expressing Dr adhesins is associated with the rearrangements of
microtubules, HeLa cells were incubated with bacterial suspensions for
3 h. Infection was interrupted at different time points, and
immunostaining was performed to visualize microtubules or microtubules
plus Dr antigen. Staining with monoclonal antibodies to either
- or
-tubulin did not reveal any reorganization of the microtubules
during infection with E. coli expressing Dr and related
adhesins (results not shown).
DAF and actin aggregate on HeLa cells interacting with polystyrene beads coated with purified Dr fimbriae. The plain polystyrene beads coated with purified Dr fimbriae displayed intense binding to HeLa cells. The control beads coated with the equivalent amount of BSA exhibited insignificant attachment. Intense circle-like staining of DAF (Fig. 3A) and less intense staining of actin (results not shown) outlining the shape of individual beads were observed on HeLa cells incubated with Dr fimbria-coated particles. The DAF clusters and aggregates of actin were not seen on HeLa cells incubated with BSA-coated beads (Figure 3B).
|
Polystyrene beads coated with purified Dr fimbrial protein internalize into HeLa cells. We hypothesized that interaction of purified Dr fimbriae protein with DAF initiates the reorganization of the cellular cytoskeleton and provides motor forces for bacterial entry. To estimate whether purified Dr fimbriae are able to promote the internalization into epithelial cells, SEM and TEM were performed on HeLa cells incubated with polystyrene beads coated with purified fimbriae and control, BSA-coated beads. After 1 h of incubation, beads coated with Dr fimbrial protein exhibited significant binding and were totally wrapped by cellular microvilli, as seen by SEM (Fig. 4A). Few adherent beads coated with BSA were found on the surface of HeLa cells after the same time of incubation (Fig. 4B). TEM confirmed the internalization of the beads with involvement of microvilli (Fig. 5A) and the intracellular location of Dr fimbria-coated beads within tight membrane-bound vacuoles (Fig. 5B). Concentrations of microfilaments, representing actin filaments, could be seen at the sites of internalization of the beads (Fig. 5A).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
We have compared the distribution of receptors and the
accumulation of cytoskeletal components that occur when recombinant E. coli strains bearing the Dr family of adhesins bind to
and enter HeLa epithelial cells. Binding of recombinant E. coli bearing Dr, Dr-II, or F1845 adhesin was associated with
intense accumulation of DAF, which outlined individual adherent
bacterial cells. Weak or occasional redistribution of receptor occurred
on monolayers infected with E. coli bearing AFA-I or AFA-III
adhesins. Our earlier experiments revealed that DAF is a ligand for the
Dr family of adhesins (17). The SCR3 domain of DAF appears
to be crucial since deletion of the SCR3 domain abolished the binding
of all Dr adhesins. Deletion of SCR2 resulted in lack of binding of all adhesins except AFA-I, which retained full binding capacity to DAF
SCR2. The deletion in SCR4 was associated with a 50% reduction of binding of AFA-I and AFA-III. It is conceivable that the different patterns of DAF clustering may be attributed to the various DAF epitopes that the recombinant strains exploit for binding.
Alternatively, the distinct morphology of the Dr family of adhesins may
affect the pattern and intensity of DAF clustering. This possibility is
supported by the fact that intense DAF clustering was associated with
fimbrial or fimbria-like structures. Weak DAF accumulation occurred in
HeLa cells infected with recombinant E. coli expressing afimbrial AFA-I and AFA-III adhesins.
The aggregation of DAF molecules in response to contact with Dr
fimbriae resembles the capping of DAF on T lymphocytes after cross-linking with anti-DAF monoclonal antibodies and anti-murine IgG
(10). The redistribution of DAF to a pole of the lymphocytes was associated with reorganization of cytoskeletal elements. We found
that both polymerized actin and
-actinin colocalized at the sites of
attachment of E. coli bearing Dr, Dr-II, F1845, and AFA-I
adhesins and formed tight profiles outlining individual bacterial
cells. The aggregates were weakly visible or not visible on the
monolayers infected with E. coli expressing AFA-III adhesin. The actin and
-actinin redistribution appears to be different from
that associated with the invasion of enteropathogenic E. coli (EPEC) or S. typhimurium into HeLa cells (3,
4). HeLa cells infected with EPEC display few aggregates located
at the center of the groups of adherent bacteria within the first
2 h of infection. The rearrangement of actin caused by infection
with recombinant E. coli expressing Dr or F1845 adhesins
occurred during the first 10 to 15 min after addition of bacteria. The
number of aggregates that outlined individual bacterial cells was
proportional to the number of bacterial cells that encountered the
surface of epithelial cells and increased with time of infection. With S. typhimurium, the redistribution of actin occurs in a
manner similar to that for E. coli expressing Dr and F1845
adhesins soon after the addition of bacteria; however, actin aggregates
are not detectable 1 h after the addition of bacteria
(4).
Ezrin, a molecule involved in linking actin filaments to transmembrane receptors, was also found to aggregate at the sites of attachment of recombinants bearing Dr, Dr-II, F1845, and AFA-I but not AFA-III (25). We found a similar but occasional and less intense pattern of staining with antibodies to tropomyosin, a molecule suggested to be involved in actin-myosin-mediated movement (24). The adherence of Dr-positive E. coli and recombinant strains expressing related adhesins does not appear to affect the distribution of focal contact proteins, such as vinculin and talin.
The internalization of Dr-positive E. coli is significantly
inhibited in the presence of the microtubule inhibitor nocodazole or
colchicine. Therefore, we expected that infection of HeLa cells would
result in rearranged microtubule organization. It was interesting that
the staining with monoclonal antibodies to either
-tubulin or
-tubulin did not reveal a redistribution of microtubules at the
areas of adherent bacteria. This finding is similar to that observed in
EPEC strains (3). Internalization of EPEC strains is blocked
by colchicine; however, internalization is not associated with visible
changes in microtubule structure. In contrast, the infection of
epithelial cells with S. typhimurium is unaffected by
nocodazole and is known to be associated with the rearrangement of
microtubules (3).
The results of EM studies on invasion of E. coli bearing Dr fimbriae led us to hypothesize that binding of bacterial ligand to the surface receptor is sufficient to trigger bacterial entry into epithelial cells (7). To provide experimental evidence supporting this hypothesis, polystyrene beads coated with purified Dr fimbrial protein were incubated with HeLa cells monolayers and examined by EM techniques. The purification of the Dr major structural subunit always resulted in a product that migrated as a single band on sodium dodecyl sulfate-polyacrylamide gels with a molecular mass of 15.6 kDa. We found that fimbrial protein-coated beads bound significantly to the microvilli and were entrapped by the microvilli of the epithelial cells; this process ultimately led to their internalization. The accumulation of DAF and actin was visible at the sites of attachment of polystyrene beads coated with Dr fimbriae. Therefore, this interaction appears to closely mimic Dr-positive E. coli-mediated internalization with the associated clustering of receptors. Studies on the invasion of E. coli carrying AFA-III adhesin showed that the bacterium-cell interaction involved two steps in which AfaE-III was required for adhesion and AfaD contributed to internalization (9). No evidence of AFA-III-mediated perturbation of actin polymerization was found (9). In conclusion, the differences in the recognition of DAF epitopes by Dr and related adhesins and/or differences in adhesin morphology may stimulate distinct patterns of cellular response. Further studies to understand how the Dr family of adhesins exploits the domains of DAF to promote their internalization into epithelial cells are in progress.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Bogdan Nowicki and Stella Nowicki for helpful discussions and critical review of the manuscript. We thank John Moulds for sending us monoclonal antibodies to DAF and David W. Niesel for providing the S. flexneri strain. We are grateful to Robert G. McConnell and his staff of Publications, Grant, and Media Support for the Department of Obstetrics and Gynecology for their assistance in the preparation of the manuscript.
This work was supported in part by grant 2RO1DK42029 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: The University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1062. Phone: (409) 772-7585. Fax: (409) 747-0475. E-mail: pgoluszk{at}utmb.edu.
Editor: P. E. Orndorff
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bergelson, J. M.,
M. Chan,
K. R. Solomon,
N. F. St. John,
H. Lin, and R. W. Finberg.
1994.
Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.
Proc. Natl. Acad. Sci. USA
91:6245-6248 |
| 2. |
Bilge, S. S.,
C. R. Clausen,
W. Lau, and S. L. Moseley.
1989.
Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells.
J. Bacteriol.
171:4281-4289 |
| 3. |
Finlay, B. B.,
I. Rosenshine,
M. S. Donnenberg, and J. B. Kaper.
1992.
Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells.
Infect. Immun.
60:2541-2543 |
| 4. |
Finlay, B. B.,
S. Ruschkowski, and S. Dedhar.
1991.
Cytoskeletal rearrangements accompanying Salmonella entry into epithelial cells.
J. Cell Sci.
99:283-296 |
| 5. | Garcia, M.-I., and C. Le Bouguénec. 1996. Role of adhesion in pathogenicity of human uropathogenic and diarrhoeogenic Escherichia coli. Bull. Inst. Pasteur 94:201-236. |
| 6. | Garcia-del Portillo, F., M. G. Pucciarelli, W. A. Jefferies, and B. B. Finlay. 1994. Salmonella typhimurium induces selective aggregation and internalization of host cell surface proteins during invasion of epithelial cells. J. Cell Sci. 107:2005-2020[Abstract]. |
| 7. | Goluszko, P., V. Popov, R. Selvarangan, S. Nowicki, T. Pham, and B. J. Nowicki. 1997. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the epithelial cell line. J. Infect. Dis. 176:158-167[Medline]. |
| 8. | Ito, S., and T. Rikihisa. 1981. Techniques for electron microscopy of rickettsiae, p. 213-227. In W. Burgdorfer, and R. L. Anacker (ed.), Rickettsiae and rickettsial diseases. Academic Press, Inc., New York, N.Y. |
| 9. | Jouve, M., M. I. Garcia, P. Courcoux, A. Labigne, P. Gounon, and C. Le Bouguénec. 1997. Adhesion to and invasion of HeLa cells by pathogenic Escherichia coli carrying the afa-3 gene cluster are mediated by the AfaE and AfaD proteins, respectively. Infect. Immun. 65:4082-4089[Abstract]. |
| 10. | Kammer, G. M., E. I. Walter, and M. E. Medof. 1988. Association of cytoskeletal reorganization with capping of the complement decay-accelerating factor on T lymphocytes. J. Immunol. 141:2924-2928[Abstract]. |
| 11. |
Karnauchow, T. M.,
D. L. Tolson,
B. A. Harrison,
E. Altman,
D. M. Lublin, and K. Dimock.
1996.
The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).
J. Virol.
70:5143-5152 |
| 12. |
Labigne-Roussel, A.,
M. A. Schmidt,
W. Walz, and S. Falkow.
1985.
Genetic organization of the afimbrial adhesin operon and nucleotide sequence from a uropathogenic Escherichia coli gene encoding an afimbrial adhesin.
J. Bacteriol.
162:1285-1292 |
| 13. |
Le Bouguénec, C.,
M. I. Garcia,
V. Quin,
J.-M. Desperier,
P. Gounon, and A. Labigne.
1993.
Characterization of plasmid-borne afa-3 gene clusters encoding afimbrial adhesins expressed by Escherichia coli strains associated with intestinal or urinary tract infections.
Infect. Immun.
61:5106-5114 |
| 14. | Lublin, D. M., and J. P. Atkinson. 1989. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7:35-58[Medline]. |
| 15. | Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 16. |
Nowicki, B.,
C. Svanborg-Edén,
R. Hull, and S. Hull.
1987.
Molecular cloning of the Escherichia coli O75X adhesin.
Infect. Immun.
55:3168-3173 |
| 17. |
Nowicki, B.,
A. Hart,
K. E. Coyne,
D. M. Lublin, and S. Nowicki.
1993.
Short Consensus Repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli Dr adhesin in a model of cell-cell interaction.
J. Exp. Med.
178:2115-2121 |
| 18. |
Nowicki, B.,
A. Labigne,
S. Moseley,
R. Hull,
S. Hull, and J. Moulds.
1990.
The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition.
Infect. Immun.
58:279-281 |
| 19. | Pham, T. Q., P. Goluszko, V. Popov, S. Nowicki, and B. J. Nowicki. 1997. Molecular cloning and characterization of Dr-II, a nonfimbrial adhesin-I-like adhesin isolated from gestational pyelonephritis-associated Escherichia coli that binds to decay-accelerating factor. Infect. Immun. 65:4309-4318[Abstract]. |
| 20. | Robinson, P. J. 1991. Signal transduction by GPI-anchored membrane proteins. Cell Biol. Int. Rep. 15:761-767[Medline]. |
| 21. | Shafren, D. R., D. J. Dorahy, R. A. Ingham, G. F. Burns, and R. D. Barry. 1997. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J. Virol. 71:4736-4743[Abstract]. |
| 22. | Shenoy-Scaria, A. M., J. Kwong, T. Fujita, M. W. Olszowy, A. S. Shaw, and D. M. Lublin. 1992. Signal transduction through decay-accelerating factor. J. Immunol. 149:3535-3541[Abstract]. |
| 23. |
tefanová, I.,
V. Hoej í,
I. J. Ansotegui,
W. Knapp, and H. Stockinger.
1991.
GPI-anchored cell-surface molecules complexed to protein tyrosine kinases.
Science
254:1016-1019 |
| 24. | Stossel, T. P. 1978. Contractile proteins in cell structure and function. Annu. Rev. Med. 29:427-475[Medline]. |
| 25. | Tsukita, S., S. Yonemura, and S. Tsukita. 1997. ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction. Curr. Opin. Cell Biol. 9:70-75[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»